Correction to: The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity (Clinical & Experimental Metastasis, (2018), 35, 7, (663-677), 10.1007/s10585-018-9919-5)

Shiue Wei Lai, Oluwaseun Adebayo Bamodu, Wen Chiuan Tsai, Yi Ming Chang, Wei Hwa Lee, Chi Tai Yeh, Tsu Yi Chao

Research output: Contribution to journalComment/debatepeer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Correction to: The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity (Clinical & Experimental Metastasis, (2018), 35, 7, (663-677), 10.1007/s10585-018-9919-5)'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry